Novartis can traces its roots back more than 250 years, with a rich history of developing innovative products. From beginnings in the production of synthetic fabric dyes (even the red paint for Ferrari), the companies that eventually became Novartis branched out into producing chemicals and ultimately pharmaceuticals. In October, it announced the spin-off of Sandoz to allow Novartis to become a “pure play” innovative medicines company. Country president Europe central cluster and country president Hungary Matt Zeller tells the Budapest Business Journal what the move means locally.
50 guests drawn from across the pharmaceutical sector attended the inaugural Pharma CEO Breakfast event at the Anantara New York Palace Budapest Hotel this morning (Tuesday, Oct. 17).
The European Commission held a high-level conference in Brussels this week (10 October) to commemorate World Mental Health Day, writes Martin Banks. The conference was hosted by Health and Food Safety Commissioner Stella Kyriakides (pictured) and it saw the participation of hundreds of representatives from EU institutions, national governments, and international organizations including UNICEF and […]
This regular section of the Budapest Business Journal features news and events from various international business chambers. For further information and to register for specific events, visit the website of the organizing chamber. If you have information for inclusion on this page, send an email in English to Annamária Bálint at annamaria.balint@bbj.hu